|
Apr 17
|
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?
|
|
Apr 11
|
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
|
|
Apr 9
|
Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know
|
|
Apr 3
|
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 18
|
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
|
|
Mar 18
|
Zacks.com featured highlights AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron
|
|
Mar 18
|
Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?
|
|
Mar 13
|
3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth Stock
|
|
Jan 24
|
Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again
|
|
Jan 9
|
Why Collegium Pharmaceutical (COLL) Stock Might be a Great Pick
|
|
Jan 4
|
Collegium (COLL) Shares Rise on Financial Outlook for 2024
|
|
Jan 4
|
Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?
|
|
Jan 3
|
Collegium Provides 2024 Financial Guidance
|
|
Dec 23
|
Collegium Pharmaceutical Inc CEO Joseph Ciaffoni Sells Company Shares
|
|
Dec 21
|
Collegium Pharmaceutical Inc CEO Joseph Ciaffoni Sells 68,768 Shares
|
|
Dec 14
|
Collegium Pharmaceutical (NASDAQ:COLL) ascends 8.3% this week, taking five-year gains to 77%
|
|
Nov 30
|
Insider Sell: EVP and General Counsel Shirley Kuhlmann Sells 25,600 Shares of Collegium ...
|
|
Nov 27
|
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
|
|
Nov 9
|
Collegium Announces $25 Million Accelerated Share Repurchase Program
|
|
Nov 9
|
Should You Be Worried About Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 5.0% Return On Equity?
|